| Patient | Diana Spencer |
|---|---|
| Date of birth | 1961-07-01 |
| Identifiers | MRN HR-ML028-SYN-TD; SSN (made up) 000-28-5197 |
| Document date | 1990-03-16 |
| Author | Imogen Castleford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Five-week review: potassium and ECG on fluoxetine 60 mg, CBT-E progress, mood, and safety. [S]
Ms. Spencer returns four weeks after the consultation. She has had seven CBT-E sessions, twice a week, and keeps her self-monitoring record every day. Binge eating with vomiting has fallen to about three times a week, and she eats breakfast and lunch on four or five days a week. She took fluoxetine 20 mg for a week, 40 mg for a week, and has taken 60 mg each morning for two weeks. She had mild nausea in the first week, which passed; she sleeps well and has had no agitation or restlessness. The nurse's phone check ten days after the start found no concerns. She has taken potassium chloride twice daily. She has not booked a dental examination. Her mood is better and she has had no thoughts of suicide or self-harm. [S]
| Element | Detail |
|---|---|
| Binge eating and vomiting | About three times a week, from seven |
| CBT-E | Seven sessions, twice weekly |
| Fluoxetine | 60 mg each morning for two weeks; nausea in the first week only |
| Mood | Better; PHQ-9 9; item 9 scored 0 |
| Dental examination | Not yet booked |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No palpitations or fainting |
| Gastrointestinal | Positive | Vomiting after binges about three times a week; nausea from fluoxetine has passed |
| Ears, nose, mouth, and throat | Positive | Teeth sensitive to cold |
| Psychiatric | Negative | Mood better; no agitation; no thoughts of suicide or self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Potassium chloride 20 mEq extended-release oral tablet, one tablet by mouth twice daily with food | One tablet by mouth twice daily with food, swallowed whole with a full glass of water | Oral route | 1990-02-09 to 1990-03-16 | completed | S |
| Fluoxetine 20 mg oral capsule, one capsule by mouth each morning for one week, then two capsules each morning for one week | One capsule each morning for one week, then two capsules each morning for one week | Oral route | 1990-02-16 to 1990-03-02 | completed | S |
| Fluoxetine 60 mg oral tablet, one tablet by mouth each morning | One tablet by mouth each morning | Oral route | 1990-03-02 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1990-03-16 | Body height | 178 | cm | S |
| 1990-03-16 | Body weight | 61.6 | kg | S |
| 1990-03-16 | Body mass index (BMI) [Ratio] | 19.4 | kg/m2 | S |
| 1990-03-16 | Systolic blood pressure | 106 | mm[Hg] | S |
| 1990-03-16 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1990-03-16 | Heart rate | 70 | /min | S |
| 1990-03-16 | Respiratory rate | 14 | /min | S |
| 1990-03-16 | Body temperature | 36.6 | Cel | S |
| 1990-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1990-03-16 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1990-03-16 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1990-03-16 | Chloride [Moles/volume] in Serum or Plasma | 101 | mmol/L | 98-107 mmol/L | Normal | S |
| 1990-03-16 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 26 | mmol/L | 22-29 mmol/L | Normal | S |
| 1990-03-16 | Creatinine [Mass/volume] in Serum or Plasma | 0.78 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1990-03-16 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1985)/1.73 sq M | 106 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1990-03-16 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.2 mg/dL | Normal | S |
| 1990-03-16 | Q-T interval corrected | 441 | ms | Above 460 ms is prolonged in women | Normal | S |
| 1990-03-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 9 | {score} | S |
Vital signs recorded on 1990-03-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; weight 61.6 kg, BMI 19.4; lying blood pressure 106/66 and pulse 70, standing 104/68 and pulse 82 after three minutes |
| Head and neck | Parotid glands a little smaller; enamel erosion unchanged |
| Psychiatric | Brighter; organized; no psychomotor agitation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Bulimia nervosa, severe: recurrent binge eating, each time with self-induced vomiting, averaging about ten episodes a week for about three years, hidden from everyone; self-worth tied closely to body shape and weight; no laxatives, diuretics, diet pills, or excessive exercise. SCOFF 4 of 5; EDE-Q global score 3.9. Findings: bilateral parotid enlargement, enamel erosion on the inner surfaces of the upper front teeth, calluses on the backs of two knuckles of the right hand, a pulse rise of 22 per minute on standing, low potassium and chloride with a raised bicarbonate, and a raised amylase; BMI 19.3. Synthetic modern episode linked to her own public account of bulimia | active | confirmed | F50.23 | S — Synthetic modern diagnosis by DSM-5-TR criteria; severity is graded by the average number of compensatory episodes a week (8 to 13 is severe). |
| Hypokalemia (potassium 3.1 mmol/L) with low chloride and metabolic alkalosis from repeated vomiting; QTc 452 ms; no palpitations, weakness, or fainting | resolved | confirmed | E87.6 | S — Synthetic presenting laboratory finding; resolved when potassium was normal on two checks. |
| Major depressive disorder, recurrent, moderate: about two months of low mood, tiredness, poor sleep, and feeling worthless and hopeless, with little pleasure in things she used to enjoy; PHQ-9 14 with item 9 scored 0; an earlier episode of depression after childbirth. Synthetic modern episode linked to her own public account of depression | active | confirmed | F33.1 | S — Synthetic modern diagnosis; the earlier episode is the post-natal depression she described publicly. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Binge-eating and vomiting frequency (her self-monitoring record) | Every visit | Completed today | About three episodes a week, from seven at the last visit and ten at intake |
| Survey | Eating Disorder Examination Questionnaire (EDE-Q) global score | Baseline, mid-treatment, and end of treatment | Up to date | Global score 3.9 at intake; mid-treatment questionnaire with the therapist at about twelve weeks |
| Examination | Weight and BMI | Every visit, and weekly in CBT-E sessions | Completed today | 61.6 kg, BMI 19.4; weighed weekly in CBT-E |
| Examination | Lying and standing pulse and blood pressure | Every visit while purging continues | Completed today | Lying 106/66, pulse 70; standing 104/68, pulse 82 (rise 12) |
| Laboratory | Potassium, chloride, bicarbonate, and creatinine | Weekly until potassium is normal twice, then at each medical visit while purging continues | Completed today | Potassium 3.9 mmol/L, the second normal value; sodium 140, chloride 101, bicarbonate 26 mmol/L; creatinine 0.78 mg/dL, eGFR 106 |
| Laboratory | Second potassium check one week after the first normal value | Weekly until potassium is normal twice | Deferred | Not drawn: the plan at the one-week visit set the next electrolyte check for this visit, four weeks later, instead of one week later. She stayed on potassium chloride throughout, had no symptoms, and potassium today is 3.9 mmol/L, so no harm resulted. Corrective action: while potassium is low or newly normal, electrolytes are drawn weekly at the laboratory between visits |
| Laboratory | Magnesium and phosphate | Baseline, and again while potassium is low | Completed today | Magnesium 2.0 mg/dL; phosphate normal at intake and not repeated |
| Laboratory | ECG with QTc | Baseline with purging or low potassium; after a QT-relevant medicine reaches its full dose while potassium has been low | Completed today | QTc 441 ms, from 452 ms, two weeks after reaching fluoxetine 60 mg |
| Examination | Parotid and dental examination; dental protection | Every visit; a dental examination soon after diagnosis and regular dental reviews while vomiting continues | Deferred | The dental examination advised at intake has not happened: she put off booking it from embarrassment. Erosion unchanged and no tooth pain, so no harm is evident yet. Corrective action: the clinic gave her a list of dentists who see people with eating disorders, and the therapist will ask about it at the next session |
| Medication safety | Oral potassium supplement | While potassium is low or vomiting is frequent | Completed today | Stopped today after a second normal potassium |
| Medication safety | Fluoxetine dose, adherence, and side effects (nausea, sleep, agitation, sexual effects, suicidal thoughts) | At the start, one to two weeks after starting or a dose change, then every visit | Completed today | 60 mg for two weeks; nausea in the first week only; no agitation or suicidal thoughts; the nurse phone check at ten days found no concerns |
| Self-management | CBT-E attendance and progress | Up to 20 sessions over 20 weeks, twice weekly for the first four weeks | Completed today | Seven sessions; self-monitoring record kept daily; weekly from next week |
| Self-management | Regular eating and dietitian review | Every visit | Completed today | Breakfast and lunch on four or five days a week |
| Survey | Depression measure (PHQ-9) | Monthly during acute treatment, then periodically | Completed today | PHQ-9 9, item 9 scored 0 |
| Survey | Suicide-risk review, safety plan, lethal means, and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; safety plan current; the 988 Suicide & Crisis Lifeline in her phone |
| Examination | Level-of-care review against thresholds for urgent or inpatient care | Every visit | Completed today | Outpatient care remains safe |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders, Fourth Edition (2023); Eating disorders: recognition and treatment (NICE guideline NG69) (2017, updated 2020); Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)
Follow-up: CBT-E weekly. Book a dental examination. Preventive visit in four weeks. Three-month review in eight weeks with electrolytes, the EDE-Q, and the PHQ-9. Next scheduled visit 1990-04-13: periodic adult preventive visit. [S]